The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Progesterone Receptor Membrane Component-1 (PGRMC1) Is the Mediator of Progesterone’s Antiapoptotic Action in Spontaneously Immortalized Granulosa Cells As Revealed by PGRMC1 Small Interfering Ribonucleic Acid Treatment and Functional Analysis of PGRMC1 Mutations
Open accessAbstract
Progesterone (P4) receptor membrane component-1 (PGRMC1) and its binding partner, plasminogen activator inhibitor 1 RNA binding protein (PAIRBP1) are thought to form a complex that functions as membrane receptor for P4. The present investigations confirm PGRMC1’s role in this membrane receptor complex by demonstrating that depleting PGMRC1 with PGRMC1 small interfering RNA results in a 60% decline in [3H]P4 binding and the loss of P4’s antiapoptotic action. Studies conducted on partially purified GFP-PGRMC1 fusion protein indicate that [3H]P4 specifically binds to PGRMC1 at a single site with an apparent Kd of about 35 nm. In addition, experiments using various deletion mutations reveal that the entire PGRMC1 molecule is required for maximal [3H]P4 binding and P4 responsiveness. Analysis of the binding data also suggests that the P4 binding site is within a segment of PGRMC1 that is composed of the transmembrane domain and the initial segment of the C terminus. Interestingly, PAIRBP1 appears to bind to the C terminus between amino acids 70–130, which is distal to the putative P4 binding site. Taken together, these data provide compelling evidence that PGRMC1 is the P4 binding protein that mediates P4’s antiapoptotic action. Moreover, the deletion mutation studies indicate that each domain of PGRMC1 plays an essential role in modulating PGRMC1’s capacity to both bind and respond to P4. Additional studies are required to more precisely delineate the role of each PGRMC1 domain in transducing P4’s antiapoptotic action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsiftsoglou, A. S., Tsamadou, A. I., & Papadopoulou, L. C. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.10.017 · Cited by 281
Cited by
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Progesterone and Breast Cancer
Trabert, B., Sherman, M. E., Kannan, N., & Stanczyk, F. Z. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnz001 · Cited by 271
Cyclic regulation of sensory perception by a female hormone alters behavior
Dey, S., Chamero, P., Pru, J. K., Chien, M.-S., Ibarra-Soria, X., Spencer, K. R., Logan, D. W., Matsunami, H., Peluso, J. J., & Stowers, L. (2015) · Cell · doi:10.1016/j.cell.2015.04.052 · Cited by 204
Self-citationRohe, H. J., Ahmed, I. S., Twist, K. E., & Craven, R. J. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.09.006 · Cited by 177
Chu, U. B., Mavlyutov, T. A., Chu, M.-L., Yang, H., Schulman, A., Mesangeau, C., McCurdy, C. R., Guo, L.-W., & Ruoho, A. E. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.10.017 · Cited by 86
Mir, S. U., Schwarze, S. R., Jin, L., Zhang, J., Friend, W., Miriyala, S., St Clair, D., & Craven, R. J. (2013) · Autophagy · doi:10.4161/auto.25889 · Cited by 69
Ahmed, I. S. A., Chamberlain, C., & Craven, R. J. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.658367 · Cited by 64
Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands
Cahill, M. A., & Medlock, A. E. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.12.020 · Cited by 60
The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology
Cahill, M. A., Jazayeri, J. A., Catalano, S. M., Toyokuni, S., Kovacevic, Z., & Richardson, D. R. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.07.004 · Cited by 40
Lee, S. R., Kwon, S. W., Kaya, P., Lee, Y. H., Lee, J. G., Kim, G., Lee, G.-S., Baek, I.-J., & Hong, E.-J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34148-6 · Cited by 37
Pathways driving the endocytosis of mutant and wild-type EGFR in cancer
Hampton, K. K., & Craven, R. J. (2014) · Oncoscience · doi:10.18632/oncoscience.67 · Cited by 35
Low affinity glucocorticoid binding site ligands as potential anti-fibrogenics
Marek, C. J., Wallace, K., Durward, E., Koruth, M., Leel, V., Leiper, L. J., & Wright, M. C. (2009) · Comparative Hepatology · doi:10.1186/1476-5926-8-1 · Cited by 17
Metadata
- Authors
- Peluso, J. J., Romak, J., & Liu, X.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-11-08
- Volume
- 149
- Issue
- 2
- Pages
- 534-543
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2043824034
- Cited by
- 195
- References
- 1
- FWCI
- 5.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.